| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC25A3 GPR89B KCNH6 ABCA3 CLCN4 SLC16A5 SLC15A1 SLC15A2 SLC6A16 SLC22A23 PIEZO1 SLC6A5 GPR89A ABCB11 GRIK4 BCL2 GRIK5 ANKH SLC7A10 TMEM63A | 6.71e-07 | 1180 | 96 | 20 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | SLC25A3 GPR89B KCNH6 ABCA3 CLCN4 SLC16A5 SLC15A1 SLC15A2 SLC6A16 SLC22A23 PIEZO1 SLC6A5 GPR89A ABCB11 GRIK4 BCL2 GRIK5 ANKH SLC7A10 TMEM63A | 2.63e-06 | 1289 | 96 | 20 | GO:0005215 |
| GeneOntologyMolecularFunction | alpha1-adrenergic receptor activity | 6.84e-05 | 3 | 96 | 2 | GO:0004937 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 6.97e-05 | 17 | 96 | 3 | GO:0008308 | |
| GeneOntologyMolecularFunction | symporter activity | 8.64e-05 | 150 | 96 | 6 | GO:0015293 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 9.10e-05 | 296 | 96 | 8 | GO:0015291 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC25A3 ABCA3 CLCN4 SLC16A5 SLC15A1 SLC15A2 SLC6A16 SLC6A5 ABCB11 ANKH | 9.91e-05 | 477 | 96 | 10 | GO:0022804 |
| GeneOntologyMolecularFunction | 5'-3' RNA exonuclease activity | 1.36e-04 | 4 | 96 | 2 | GO:0004534 | |
| GeneOntologyMolecularFunction | peptide:proton symporter activity | 1.36e-04 | 4 | 96 | 2 | GO:0015333 | |
| GeneOntologyMolecularFunction | gated channel activity | 2.08e-04 | 334 | 96 | 8 | GO:0022836 | |
| GeneOntologyMolecularFunction | dipeptide transmembrane transporter activity | 2.27e-04 | 5 | 96 | 2 | GO:0071916 | |
| GeneOntologyMolecularFunction | solute:proton symporter activity | 2.29e-04 | 25 | 96 | 3 | GO:0015295 | |
| GeneOntologyMolecularFunction | kainate selective glutamate receptor activity | 3.39e-04 | 6 | 96 | 2 | GO:0015277 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase kinase activity | 3.39e-04 | 6 | 96 | 2 | GO:0008349 | |
| GeneOntologyMolecularFunction | alpha-adrenergic receptor activity | 3.39e-04 | 6 | 96 | 2 | GO:0004936 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC25A3 GPR89B KCNH6 CLCN4 SLC15A1 SLC15A2 PIEZO1 SLC6A5 GPR89A GRIK4 GRIK5 TMEM63A | 4.15e-04 | 793 | 96 | 12 | GO:0015075 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 4.93e-04 | 207 | 96 | 6 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 5.06e-04 | 208 | 96 | 6 | GO:0005342 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 5.34e-04 | 293 | 96 | 7 | GO:0008514 | |
| GeneOntologyMolecularFunction | tripeptide transmembrane transporter activity | 8.06e-04 | 9 | 96 | 2 | GO:0042937 | |
| GeneOntologyMolecularFunction | peptide transmembrane transporter activity | 8.06e-04 | 9 | 96 | 2 | GO:1904680 | |
| GeneOntologyMolecularFunction | RNA exonuclease activity, producing 5'-phosphomonoesters | 9.35e-04 | 40 | 96 | 3 | GO:0016896 | |
| GeneOntologyMolecularFunction | channel activity | 9.58e-04 | 525 | 96 | 9 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 9.70e-04 | 526 | 96 | 9 | GO:0022803 | |
| GeneOntologyMolecularFunction | adrenergic receptor activity | 1.00e-03 | 10 | 96 | 2 | GO:0004935 | |
| GeneOntologyMolecularFunction | G protein-coupled amine receptor activity | 1.01e-03 | 41 | 96 | 3 | GO:0008227 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 1.10e-03 | 430 | 96 | 8 | GO:0004175 | |
| GeneOntologyMolecularFunction | RNA exonuclease activity | 1.32e-03 | 45 | 96 | 3 | GO:0004532 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.65e-03 | 105 | 96 | 4 | GO:0015171 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.66e-03 | 459 | 96 | 8 | GO:0005216 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 2.31e-03 | 15 | 96 | 2 | GO:0008559 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 2.61e-03 | 119 | 96 | 4 | GO:0015294 | |
| GeneOntologyMolecularFunction | oligopeptide transmembrane transporter activity | 2.63e-03 | 16 | 96 | 2 | GO:0035673 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 2.69e-03 | 120 | 96 | 4 | GO:0004222 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 2.97e-03 | 17 | 96 | 2 | GO:0004970 | |
| GeneOntologyMolecularFunction | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 3.32e-03 | 62 | 96 | 3 | GO:0016796 | |
| GeneOntologyMolecularFunction | ligand-gated sodium channel activity | 3.33e-03 | 18 | 96 | 2 | GO:0015280 | |
| GeneOntologyMolecularFunction | 5'-3' exonuclease activity | 3.33e-03 | 18 | 96 | 2 | GO:0008409 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 3.33e-03 | 18 | 96 | 2 | GO:0008381 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC25A3 KCNH6 CLCN4 SLC15A1 SLC15A2 SLC6A5 GRIK4 GRIK5 ANKH TMEM63A | 3.49e-03 | 758 | 96 | 10 | GO:0015318 |
| GeneOntologyMolecularFunction | RNA nuclease activity | 4.22e-03 | 136 | 96 | 4 | GO:0004540 | |
| GeneOntologyMolecularFunction | peptidase activity | 4.23e-03 | 654 | 96 | 9 | GO:0008233 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC25A3 KCNH6 SLC15A1 SLC15A2 PIEZO1 SLC6A5 GRIK4 GRIK5 TMEM63A | 4.67e-03 | 664 | 96 | 9 | GO:0008324 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 4.67e-03 | 140 | 96 | 4 | GO:0099094 | |
| GeneOntologyMolecularFunction | phosphate transmembrane transporter activity | 5.89e-03 | 24 | 96 | 2 | GO:0005315 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 5.89e-03 | 24 | 96 | 2 | GO:0099507 | |
| GeneOntologyBiologicalProcess | tripeptide import across plasma membrane | 2.10e-05 | 2 | 95 | 2 | GO:0140207 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC25A3 GPR89B KCNH6 ADRA1A CLCN4 SLC15A1 SLC15A2 SLC6A16 PIEZO1 SLC6A5 GPR89A STEAP4 GRIK4 BCL2 GRIK5 TMEM63A | 4.66e-05 | 1115 | 95 | 16 | GO:0034220 |
| GeneOntologyBiologicalProcess | positive regulation of heart rate by epinephrine-norepinephrine | 1.25e-04 | 4 | 95 | 2 | GO:0001996 | |
| GeneOntologyBiologicalProcess | positive regulation of the force of heart contraction by epinephrine-norepinephrine | 1.25e-04 | 4 | 95 | 2 | GO:0001997 | |
| GeneOntologyBiologicalProcess | DNA repair-dependent chromatin remodeling | 1.57e-04 | 23 | 95 | 3 | GO:0140861 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC25A3 GPR89B KCNH6 ADRA1A CLCN4 SLC15A1 SLC15A2 SLC6A16 SLC22A23 PIEZO1 SLC6A5 GPR89A STEAP4 GRIK4 BCL2 GRIK5 TMEM63A | 1.63e-04 | 1374 | 95 | 17 | GO:0006811 |
| GeneOntologyBiologicalProcess | neuron-glial cell signaling | 2.08e-04 | 5 | 95 | 2 | GO:0150099 | |
| GeneOntologyBiologicalProcess | oligopeptide import across plasma membrane | 2.08e-04 | 5 | 95 | 2 | GO:0140205 | |
| GeneOntologyBiologicalProcess | dipeptide import across plasma membrane | 2.08e-04 | 5 | 95 | 2 | GO:0140206 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glycinergic | 2.08e-04 | 5 | 95 | 2 | GO:0060012 | |
| GeneOntologyBiologicalProcess | positive regulation of the force of heart contraction by chemical signal | 2.08e-04 | 5 | 95 | 2 | GO:0003099 | |
| GeneOntologyCellularComponent | Golgi membrane | ACER2 GPR89B NAPEPLD OTOF SURF4 DHCR24 ARFGEF2 GPR89A ABCB11 STEAP4 PGAP4 HEPACAM2 GOLT1A RIC1 DOP1B | 9.83e-07 | 721 | 96 | 15 | GO:0000139 |
| GeneOntologyCellularComponent | presynaptic membrane | 2.90e-04 | 277 | 96 | 7 | GO:0042734 | |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 3.09e-04 | 6 | 96 | 2 | GO:0032983 | |
| GeneOntologyCellularComponent | early endosome membrane | 4.40e-04 | 212 | 96 | 6 | GO:0031901 | |
| Domain | Put_53exo | 2.51e-05 | 2 | 94 | 2 | IPR004859 | |
| Domain | LEDGF | 2.51e-05 | 2 | 94 | 2 | PF11467 | |
| Domain | LEDGF | 2.51e-05 | 2 | 94 | 2 | IPR021567 | |
| Domain | 5_3_exoribonuclease | 2.51e-05 | 2 | 94 | 2 | IPR027073 | |
| Domain | Oligopep_transport | 2.51e-05 | 2 | 94 | 2 | IPR004768 | |
| Domain | XRN_N | 2.51e-05 | 2 | 94 | 2 | PF03159 | |
| Domain | CK1gamma_C | 7.49e-05 | 3 | 94 | 2 | PF12605 | |
| Domain | Casein_kinase-1_gamma_C | 7.49e-05 | 3 | 94 | 2 | IPR022247 | |
| Domain | PTR2_symporter_CS | 7.49e-05 | 3 | 94 | 2 | IPR018456 | |
| Domain | PTR2_1 | 7.49e-05 | 3 | 94 | 2 | PS01022 | |
| Domain | PWWP | 1.32e-04 | 20 | 94 | 3 | SM00293 | |
| Domain | MAPKKKK | 1.49e-04 | 4 | 94 | 2 | IPR021160 | |
| Domain | PTR2_2 | 1.49e-04 | 4 | 94 | 2 | PS01023 | |
| Domain | PWWP | 2.03e-04 | 23 | 94 | 3 | PF00855 | |
| Domain | PWWP_dom | 2.03e-04 | 23 | 94 | 3 | IPR000313 | |
| Domain | PWWP | 2.31e-04 | 24 | 94 | 3 | PS50812 | |
| Domain | POT_fam | 2.48e-04 | 5 | 94 | 2 | IPR000109 | |
| Domain | PTR2 | 2.48e-04 | 5 | 94 | 2 | PF00854 | |
| Domain | Carboxylesterase_B_AS | 6.88e-04 | 8 | 94 | 2 | IPR019826 | |
| Domain | CARBOXYLESTERASE_B_1 | 6.88e-04 | 8 | 94 | 2 | PS00122 | |
| Domain | MetalloPept_cat_dom | 7.44e-04 | 81 | 94 | 4 | IPR024079 | |
| Domain | - | 7.44e-04 | 81 | 94 | 4 | 3.40.390.10 | |
| Domain | ADR_fam | 1.10e-03 | 10 | 94 | 2 | IPR002233 | |
| Domain | Carboxylesterase_B_CS | 1.89e-03 | 13 | 94 | 2 | IPR019819 | |
| Domain | CARBOXYLESTERASE_B_2 | 2.19e-03 | 14 | 94 | 2 | PS00941 | |
| Domain | COesterase | 2.19e-03 | 14 | 94 | 2 | PF00135 | |
| Domain | CarbesteraseB | 2.19e-03 | 14 | 94 | 2 | IPR002018 | |
| Domain | CNH | 2.19e-03 | 14 | 94 | 2 | SM00036 | |
| Domain | CNH | 2.52e-03 | 15 | 94 | 2 | PF00780 | |
| Domain | CNH | 2.52e-03 | 15 | 94 | 2 | PS50219 | |
| Domain | CNH_dom | 2.52e-03 | 15 | 94 | 2 | IPR001180 | |
| Domain | Iontro_rcpt | 3.64e-03 | 18 | 94 | 2 | IPR001320 | |
| Domain | Lig_chan-Glu_bd | 3.64e-03 | 18 | 94 | 2 | PF10613 | |
| Domain | Iono_rcpt_met | 3.64e-03 | 18 | 94 | 2 | IPR001508 | |
| Domain | Glu/Gly-bd | 3.64e-03 | 18 | 94 | 2 | IPR019594 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 3.64e-03 | 18 | 94 | 2 | PS00754 | |
| Domain | Lig_chan-Glu_bd | 3.64e-03 | 18 | 94 | 2 | SM00918 | |
| Domain | Pept_M10A_stromelysin-type | 3.64e-03 | 18 | 94 | 2 | IPR016293 | |
| Domain | Lig_chan | 3.64e-03 | 18 | 94 | 2 | PF00060 | |
| Domain | PBPe | 3.64e-03 | 18 | 94 | 2 | SM00079 | |
| Domain | SNF | 4.05e-03 | 19 | 94 | 2 | PF00209 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 4.05e-03 | 19 | 94 | 2 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 4.05e-03 | 19 | 94 | 2 | PS50267 | |
| Domain | Na/ntran_symport | 4.05e-03 | 19 | 94 | 2 | IPR000175 | |
| Domain | PG_binding_1 | 4.49e-03 | 20 | 94 | 2 | PF01471 | |
| Domain | Peptidoglycan-bd-like | 4.49e-03 | 20 | 94 | 2 | IPR002477 | |
| Domain | MFS_dom | 4.69e-03 | 134 | 94 | 4 | IPR020846 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | INTU SLC22A23 SCARB1 TBCK ASS1 RIMS1 BAIAP2 PRORP ZSWIM1 MMP16 USP3 CNOT1 ANKH RIC1 ADGRG6 TMEM63A | 3.06e-06 | 1489 | 96 | 16 | 28611215 |
| Pubmed | 4.09e-06 | 234 | 96 | 7 | 36243803 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 16337983 | ||
| Pubmed | ABC transporter expression profiling after ischemic reperfusion injury in mouse kidney. | 7.54e-06 | 2 | 96 | 2 | 16612327 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 17283256 | ||
| Pubmed | Alpha1-adrenergic receptors prevent a maladaptive cardiac response to pressure overload. | 7.54e-06 | 2 | 96 | 2 | 16585965 | |
| Pubmed | High-affinity kainate receptor subunits are necessary for ionotropic but not metabotropic signaling. | 7.54e-06 | 2 | 96 | 2 | 19778510 | |
| Pubmed | LEDGF and HDGF2 relieve the nucleosome-induced barrier to transcription in differentiated cells. | 7.54e-06 | 2 | 96 | 2 | 31616795 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 12888550 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 11944083 | ||
| Pubmed | Comparison of human and monkey peptide transporters: PEPT1 and PEPT2. | 7.54e-06 | 2 | 96 | 2 | 15981923 | |
| Pubmed | Peptide transporters and their roles in physiological processes and drug disposition. | 7.54e-06 | 2 | 96 | 2 | 18668438 | |
| Pubmed | Lack of interaction between the peptidomimetic substrates captopril and cephradine. | 7.54e-06 | 2 | 96 | 2 | 19246733 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 19540213 | ||
| Pubmed | HRP-2 determines HIV-1 integration site selection in LEDGF/p75 depleted cells. | 7.54e-06 | 2 | 96 | 2 | 23046603 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 12782680 | ||
| Pubmed | Subunit-specific desensitization of heteromeric kainate receptors. | 7.54e-06 | 2 | 96 | 2 | 20026616 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 15105424 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 22120526 | ||
| Pubmed | Transport of angiotensin-converting enzyme inhibitors by H+/peptide transporters revisited. | 7.54e-06 | 2 | 96 | 2 | 18713951 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 18367661 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 22572823 | ||
| Pubmed | Tissue distribution and thyroid hormone regulation of Pept1 and Pept2 mRNA in rodents. | 7.54e-06 | 2 | 96 | 2 | 16202478 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 22203159 | ||
| Pubmed | The bioactive dipeptide anserine is transported by human proton-coupled peptide transporters. | 7.54e-06 | 2 | 96 | 2 | 20067523 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 15797927 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 21223784 | ||
| Pubmed | {alpha}1-Adrenergic receptor subtypes in nonfailing and failing human myocardium. | 7.54e-06 | 2 | 96 | 2 | 19919991 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 12093905 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 18802028 | ||
| Pubmed | Interaction of HRP-2 isoforms with HDGF: chromatin binding of a specific heteromer. | 7.54e-06 | 2 | 96 | 2 | 22212508 | |
| Pubmed | GPHR is a novel anion channel critical for acidification and functions of the Golgi apparatus. | 7.54e-06 | 2 | 96 | 2 | 18794847 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 23717684 | ||
| Pubmed | Abnormal myocardial contraction in alpha(1A)- and alpha(1B)-adrenoceptor double-knockout mice. | 7.54e-06 | 2 | 96 | 2 | 14519431 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 25673723 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.14e-05 | 202 | 96 | 6 | 33005030 | |
| Pubmed | Gene expressions and mechanical functions of α1-adrenoceptor subtypes in mouse ureter. | 2.26e-05 | 3 | 96 | 2 | 19259685 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 18552157 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 8183249 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 17384126 | ||
| Pubmed | Role of α₁-adrenoceptor subtypes in pupil dilation studied with gene-targeted mice. | 2.26e-05 | 3 | 96 | 2 | 25425303 | |
| Pubmed | Localizations and expressions of alpha-1A, alpha-1B and alpha-1D adrenoceptors in human ureter. | 2.26e-05 | 3 | 96 | 2 | 17973108 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 33477970 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 18523139 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 8024574 | ||
| Pubmed | Alpha1-adrenoceptors are required for normal male sexual function. | 2.26e-05 | 3 | 96 | 2 | 17603545 | |
| Pubmed | Examination of alpha 1 adrenoceptor subtypes in the human ureter. | 2.26e-05 | 3 | 96 | 2 | 17681068 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 9299445 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 15371438 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 14659805 | ||
| Pubmed | The presence and distribution of alpha adrenergic receptors in human renal pelvis and calyces. | 2.26e-05 | 3 | 96 | 2 | 23877383 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 7595531 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 12595294 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 16325263 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 31757425 | ||
| Pubmed | Functional role of α1-adrenoceptor subtypes in murine ophthalmic arteries. | 2.26e-05 | 3 | 96 | 2 | 21613371 | |
| Pubmed | Downregulation of peptide transporters PEPT1 and PEPT2 by oxidative stress responsive kinase OSR1. | 2.26e-05 | 3 | 96 | 2 | 25531100 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 32220963 | ||
| Pubmed | Alpha- and beta-adrenergic receptor polymorphisms in hypertensive and normotensive offspring. | 2.26e-05 | 3 | 96 | 2 | 16645408 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 29089212 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 7815325 | ||
| Pubmed | Role of α1-adrenoceptor subtypes on corneal epithelial thickness and cell proliferation in mice. | 2.26e-05 | 3 | 96 | 2 | 30257104 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 18257748 | ||
| Pubmed | Specific interactions between gC1qR and alpha1-adrenoceptor subtypes. | 2.26e-05 | 3 | 96 | 2 | 14626446 | |
| Pubmed | Differential regulation of the cell cycle by alpha1-adrenergic receptor subtypes. | 2.26e-05 | 3 | 96 | 2 | 15297446 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 10493741 | ||
| Pubmed | Effect of Janus kinase 3 on the peptide transporters PEPT1 and PEPT2. | 2.26e-05 | 3 | 96 | 2 | 23934551 | |
| Pubmed | Expression profile and functional activity of peptide transporters in prostate cancer cells. | 2.26e-05 | 3 | 96 | 2 | 22950754 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 12409310 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 2.52e-05 | 208 | 96 | 6 | 33230847 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 34624089 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 32085899 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 14551195 | ||
| Pubmed | Distribution of kainate receptor subunits at hippocampal mossy fiber synapses. | 4.51e-05 | 4 | 96 | 2 | 12954862 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 28219977 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 21366347 | ||
| Pubmed | The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology. | 4.51e-05 | 4 | 96 | 2 | 12905028 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 15231500 | ||
| Pubmed | Cerebellar Neurodegeneration and Neuronal Circuit Remodeling in Golgi pH Regulator-Deficient Mice. | 4.51e-05 | 4 | 96 | 2 | 31118204 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 25775528 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 28835457 | ||
| Pubmed | Developmental expression patterns of kainate receptors in the mouse spinal cord. | 7.50e-05 | 5 | 96 | 2 | 23076118 | |
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 28228252 | ||
| Pubmed | Development of laminar distributions of kainate receptors in the somatosensory cortex of mice. | 7.50e-05 | 5 | 96 | 2 | 9593973 | |
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 24844469 | ||
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 26448475 | ||
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 8288598 | ||
| Pubmed | Kainate receptors: pharmacology, function and therapeutic potential. | 7.50e-05 | 5 | 96 | 2 | 18793656 | |
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 12223554 | ||
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 21680713 | ||
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 18358623 | ||
| Pubmed | Preferential assembly of heteromeric kainate and AMPA receptor amino terminal domains. | 7.50e-05 | 5 | 96 | 2 | 29058671 | |
| Pubmed | Expression of adrenergic receptors in mouse preimplantation embryos and ovulated oocytes. | 1.12e-04 | 6 | 96 | 2 | 17636168 | |
| Pubmed | 1.12e-04 | 6 | 96 | 2 | 25840998 | ||
| Pubmed | Interaction of Brn3a and HIPK2 mediates transcriptional repression of sensory neuron survival. | 1.12e-04 | 6 | 96 | 2 | 15492043 | |
| Pubmed | 1.12e-04 | 6 | 96 | 2 | 12184796 | ||
| Pubmed | 1.12e-04 | 6 | 96 | 2 | 24567387 | ||
| Pubmed | N-glycan content modulates kainate receptor functional properties. | 1.12e-04 | 6 | 96 | 2 | 28714086 | |
| Pubmed | Yeast two-hybrid screening for proteins that interact with alpha1-adrenergic receptors. | 1.12e-04 | 6 | 96 | 2 | 15525470 | |
| Pubmed | 1.12e-04 | 6 | 96 | 2 | 28862946 | ||
| Interaction | VIPR2 interactions | 2.32e-06 | 194 | 89 | 8 | int:VIPR2 | |
| Interaction | RTL1 interactions | 6.86e-06 | 9 | 89 | 3 | int:RTL1 | |
| Interaction | PIGN interactions | 1.55e-05 | 71 | 89 | 5 | int:PIGN | |
| Cytoband | 3q27.2 | 2.82e-04 | 12 | 96 | 2 | 3q27.2 | |
| Cytoband | 1q21-q23 | 3.32e-04 | 13 | 96 | 2 | 1q21-q23 | |
| GeneFamily | Solute carriers | SLC25A3 SLC16A5 SLC15A1 SLC15A2 SLC6A16 SLC22A23 SLC6A5 SLC7A10 | 5.83e-05 | 395 | 62 | 8 | 752 |
| GeneFamily | Mitogen-activated protein kinase kinase kinase kinases | 1.15e-04 | 5 | 62 | 2 | 655 | |
| GeneFamily | Glutamate ionotropic receptor kainate type subunits | 1.15e-04 | 5 | 62 | 2 | 1199 | |
| GeneFamily | Adrenoceptors | 4.10e-04 | 9 | 62 | 2 | 169 | |
| GeneFamily | PWWP domain containing | 2.56e-03 | 22 | 62 | 2 | 1147 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 3.04e-03 | 24 | 62 | 2 | 891 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.38e-08 | 169 | 96 | 7 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.68e-06 | 167 | 96 | 6 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.80e-06 | 169 | 96 | 6 | 96a2aec9acf8a6f966973c035e5ade456cf47772 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 2.77e-06 | 182 | 96 | 6 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | 356C-Epithelial_cells-Epithelial-B_(AT2)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.36e-06 | 197 | 96 | 6 | 06ed8f293d4ee89f14dc2f43d6cae93bbc02508a | |
| ToppCell | 356C-Epithelial_cells-Epithelial-B_(AT2)|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.36e-06 | 197 | 96 | 6 | c115d0a45545ed24259ad88872231bf4d4d389d2 | |
| ToppCell | IPF-Epithelial-PNEC|IPF / Disease state, Lineage and Cell class | 2.44e-05 | 159 | 96 | 5 | adec82df944fe8699a69ca52534353bef100f2f9 | |
| ToppCell | IPF-Epithelial-PNEC|World / Disease state, Lineage and Cell class | 2.59e-05 | 161 | 96 | 5 | 133833729ba8b6d3eef326590ca7476b17602cbb | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.18e-05 | 168 | 96 | 5 | 8e9046b661642293eee640ead91d43db9d8daae0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.18e-05 | 168 | 96 | 5 | c7d66e5d9311ceaab3f144f1516b49b8812976b8 | |
| ToppCell | 10x_5'_v1-Neoplastic|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.86e-05 | 175 | 96 | 5 | 379f595be2273f662064c920d195a30491aa88d6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-05 | 180 | 96 | 5 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | RA-11._Adipocyte|RA / Chamber and Cluster_Paper | 4.41e-05 | 180 | 96 | 5 | d48a3d27357f7d184132a6805950f93080146b59 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.53e-05 | 181 | 96 | 5 | ab66a89f316b935d9ba1277426d976b1e9e39757 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.90e-05 | 184 | 96 | 5 | ce31684772e47a294155f368e50b49753f7c8e87 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.03e-05 | 185 | 96 | 5 | 1b990e3089772be2b38c6d7ea0d1bf22461ae3ea | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.16e-05 | 186 | 96 | 5 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.29e-05 | 187 | 96 | 5 | f1d0fc625e0e7881b3f290742fd7148d995eb71e | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.29e-05 | 187 | 96 | 5 | 02e7246ef5ad41773d14426254e139b156d45c1d | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.29e-05 | 187 | 96 | 5 | 08c73d125e0638c9e9878165bba2442c266c8a48 | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.43e-05 | 188 | 96 | 5 | 5eb107122064f0a99dfd445cc87d3766f7257216 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.43e-05 | 188 | 96 | 5 | 5901b276f2379abf486b8285957277e95f08464e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 5.43e-05 | 188 | 96 | 5 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.70e-05 | 190 | 96 | 5 | e1b721bb74561fe51c53328a0394c9954e489049 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 5.85e-05 | 191 | 96 | 5 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.14e-05 | 193 | 96 | 5 | 402aad2f9e789ad1f2e1536cdc9ce61de7625427 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-05 | 193 | 96 | 5 | a5695ce2e24a62026ae28f3dea07ca4a435206b8 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.14e-05 | 193 | 96 | 5 | 7ee3b1ef5c455f321b4e154ae62c69543fe9b30e | |
| ToppCell | AT2|World / shred by cell class for parenchyma | 6.30e-05 | 194 | 96 | 5 | e773f5ef3abce7113a6b7cc7cbe68de873d4a17f | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.45e-05 | 195 | 96 | 5 | 2a9a36df1dbc4eac77a8ddbe939ec8a8d6c41464 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.45e-05 | 195 | 96 | 5 | 6617abca0009ad3d8731f515f91ab275f9ea4c40 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT2-AT2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.45e-05 | 195 | 96 | 5 | 6867f9c56ea27a17c8c4099aae0d79903c3748a5 | |
| ToppCell | AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 6.45e-05 | 195 | 96 | 5 | b0cea3f4e59635913d243612f2e8cf4c7b34e726 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.45e-05 | 195 | 96 | 5 | fc0ae145a2118df7cbbc9ac4ca9dc12d26c087c4 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.45e-05 | 195 | 96 | 5 | 576142b4e75457c0973051bccc4163bd624496af | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.45e-05 | 195 | 96 | 5 | 8f151066ad3ebd9661ea0b733f03c2ce1518f9ad | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.45e-05 | 195 | 96 | 5 | 3e24570def013d5b0b1ef1d7a5ced7dfd922590b | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.45e-05 | 195 | 96 | 5 | 955a0a7244cd7eaf006a39e1bd03333baf6f30a4 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.45e-05 | 195 | 96 | 5 | 37aa6e4123d37de4de42ca68d3020f2a7686ce02 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.45e-05 | 195 | 96 | 5 | eec187c087e432417bc346c5d3ead72f58bf3215 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.61e-05 | 196 | 96 | 5 | 4bdc304c0c9d8bebe1a6a8a27e44acd1e8113725 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.61e-05 | 196 | 96 | 5 | 83aeb96a33802949238d8a097086a1812201d1b5 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Club|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.61e-05 | 196 | 96 | 5 | 057d150bdf0cad959fd03ec2d1560a96ba03fae9 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-A_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.77e-05 | 197 | 96 | 5 | 0de77f04612b66cc637dab5d5432c6e711e5964e | |
| ToppCell | AT2_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.77e-05 | 197 | 96 | 5 | 42e49a8ce3118db6c2fd620d70c480b75143c828 | |
| ToppCell | ASK452-Epithelial-Transformed_epithelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.77e-05 | 197 | 96 | 5 | b22a79a5922c865a360e2afc5506a08a512fa76a | |
| ToppCell | NS-critical-d_16-33-Epithelial-Secretory|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.77e-05 | 197 | 96 | 5 | a72047b7428c0d4aaf016c1ac23dc30919260fd8 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-A_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.77e-05 | 197 | 96 | 5 | a01640e31fc33c1ab512b4d3eddae8342ecf182c | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.93e-05 | 198 | 96 | 5 | 8f25e8dff42bad8e779ca618bdb1cb1610667962 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.93e-05 | 198 | 96 | 5 | 778fee7020c82d11ff3984a8e482a23e5d58165f | |
| ToppCell | PSB-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.93e-05 | 198 | 96 | 5 | e4cbe4032dba0da3fd46817ea9ad86ba9217f747 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.93e-05 | 198 | 96 | 5 | e3e0aa3ef20b2370f5b133048510677aaa562dfa | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.93e-05 | 198 | 96 | 5 | c48b3f026b16d48b8eca9f74dc1e3f3f39a89322 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-mature_enterocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.10e-05 | 199 | 96 | 5 | a10768e1cddd2d38291c30d24820a94040a72211 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.10e-05 | 199 | 96 | 5 | 914f66e2b4af323d09fa2340a39cf8051d00a422 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.10e-05 | 199 | 96 | 5 | f26c20f5d7470e90eaa79613d0b87bd4865585a8 | |
| ToppCell | Biopsy_IPF-Epithelial-SCGB3A2+|Biopsy_IPF / Sample group, Lineage and Cell type | 7.27e-05 | 200 | 96 | 5 | 2aaf130d702d18c277d16b6800f006a53ed653fb | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.27e-05 | 200 | 96 | 5 | 3e13c9a4ba99a7dfbf738b0fb63fb54b4dee5897 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_secretory|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.27e-05 | 200 | 96 | 5 | 8f811ddd84c037a250d124496b0fbb2e4717011c | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.27e-05 | 200 | 96 | 5 | 73bfdf068a8ecbefc1e6afe9686df73658ee042f | |
| ToppCell | Biopsy_Other_PF-Epithelial-SCGB3A2+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 7.27e-05 | 200 | 96 | 5 | 631550dc34bcb605ab726645f4024d7828bb7975 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-6|TCGA-Lung / Sample_Type by Project: Shred V9 | 8.18e-05 | 106 | 96 | 4 | c36911774d31fdea680e3db300ce9064f5b69554 | |
| ToppCell | Control-Epithelial_alveolar-Mes-Like-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-04 | 127 | 96 | 4 | 556aaf88719c83f307fa50dfac151136ed05c8ad | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-04 | 141 | 96 | 4 | 9a0f4bee2893da1b13ab89494e6159821d53538b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-04 | 144 | 96 | 4 | 5665dd2839b6c8ddbf5ddb2d22e1ee6073f74c3b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-04 | 144 | 96 | 4 | cc11cce43d1af8ac63140d05faf215ae9a10cde1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.80e-04 | 146 | 96 | 4 | deeb2c90a478deac7805e1f0d1466bf5bc42f746 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.27e-04 | 152 | 96 | 4 | ca23261d8ef263cc697b8d7e7cb2afec8bc564f2 | |
| ToppCell | Club_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 3.35e-04 | 153 | 96 | 4 | 77030b0e033f3635b1bbe7552a28c074ea7bb106 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Ndst4_(Superficial_layer_pyramidal_cells--dorsal_endopiriform_nucleus_or_piriform_cortex)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.41e-04 | 63 | 96 | 3 | 1f609765ed8b3a09095427da5dab7ba03a763192 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.52e-04 | 155 | 96 | 4 | 62b59cb32b12bd55b19e98786a866d788fc9e4bf | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intestinal_macrophages|Liver / Manually curated celltypes from each tissue | 3.61e-04 | 156 | 96 | 4 | 9a897fc79c4fae94c5f2e9012d65297f9225e5e3 | |
| ToppCell | 18-Distal-Epithelial-Basal_cell|Distal / Age, Tissue, Lineage and Cell class | 3.78e-04 | 158 | 96 | 4 | 183f445967e09e871c93d8e94781ed9fec894169 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma|TCGA-Bladder / Sample_Type by Project: Shred V9 | 3.78e-04 | 158 | 96 | 4 | dc559503bab3ec1b9ea54ef2e896d1be33e5344c | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.06e-04 | 161 | 96 | 4 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | facs-Heart-LA-24m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-04 | 161 | 96 | 4 | 248487415a0601d57ef2a6692e22a61368d0b9c8 | |
| ToppCell | Club_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 4.06e-04 | 161 | 96 | 4 | 342f5c61d37df61b35c18f5d258043a8f5cef629 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.16e-04 | 162 | 96 | 4 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Serous_adenocarcinoma|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 4.36e-04 | 164 | 96 | 4 | 08c725548e751f815b4df778607270498204b353 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.36e-04 | 164 | 96 | 4 | b0ed8cb6000ce8bf94444307e4b7b3574fa3fab2 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.36e-04 | 164 | 96 | 4 | 3aea6207a011ad55a1aeb2ed9fb54d31b23694b5 | |
| ToppCell | Multiple_Sclerosis-Other-HSPC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 4.36e-04 | 164 | 96 | 4 | 6af5529507d695b347adee4be5ead70f56c9cf55 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.36e-04 | 164 | 96 | 4 | be49af6335f2505065cde2cb9800e4a5516811b1 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.36e-04 | 164 | 96 | 4 | 9e16e52f5a634585f26021bcce9b5d5992ff6db0 | |
| ToppCell | Club-club-12|World / Class top | 4.46e-04 | 165 | 96 | 4 | 9b7a31cbdcd2f96b8bd08a4cd4141b92bd5e9062 | |
| ToppCell | droplet-Fat-SCAT-30m-Lymphocytic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-04 | 166 | 96 | 4 | 67370c49d7aedcb4eca802095f06b30f6bbf8919 | |
| ToppCell | droplet-Fat-SCAT-30m-Lymphocytic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-04 | 166 | 96 | 4 | 7f4e5976ede6478636aa567d6fc2b56ff7295fb8 | |
| ToppCell | facs-Kidney-nan-24m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-04 | 166 | 96 | 4 | fe87b444fc0ef6fc20c646c9d2c3c8ce916a70c0 | |
| ToppCell | Club-club-2|World / Class top | 4.56e-04 | 166 | 96 | 4 | 56f11efb6b686b3ee2c34a051f626e3d761b5112 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.77e-04 | 168 | 96 | 4 | de0b00bc405c898d08a06b2e585fb62c0ab9a66e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.88e-04 | 169 | 96 | 4 | 4b3a7b4a497178799b6b2f0b744f5fb752cee31a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.88e-04 | 169 | 96 | 4 | a4fd646b9bf87225131fca530bd6b52df9eaf489 | |
| ToppCell | Ionocyte|World / Class top | 4.99e-04 | 170 | 96 | 4 | d2e592f2a679e6a8d32f2b752d9a3c493e50ced4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2-Exc_L5_FEZF2_SCN7A|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.99e-04 | 170 | 96 | 4 | a0047551619547971d55165156f61f090948f902 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-04 | 170 | 96 | 4 | 833b4f44ea1fa673dfc6b43ce45a79fe68ae3b05 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.10e-04 | 171 | 96 | 4 | 26b34dc069cc15b75a0c13cb8c5d81e074788160 | |
| ToppCell | TCGA-Prostate-Solid_Tissue_Normal-Prostate_normal_tissue-Prostate_normal_tissue-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.10e-04 | 171 | 96 | 4 | cafcb7714110cb361808dbe4b9a4963bb71f5129 | |
| ToppCell | metastatic_Brain-Fibroblasts-Undetermined|Fibroblasts / Location, Cell class and cell subclass | 5.21e-04 | 172 | 96 | 4 | c3822ff7329c3ac38c68c5c38cd67c390682e2a6 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-04 | 172 | 96 | 4 | 7fb31ccbcd0204c3612986a6bc20d57ed6825e9c | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-04 | 172 | 96 | 4 | 2a4614b3d25e8c6b095e6992d8ca35371dcdb5e1 | |
| Drug | Doxazosin | 1.39e-06 | 6 | 95 | 3 | DB00590 | |
| Drug | Prazosin | 1.39e-06 | 6 | 95 | 3 | DB00457 | |
| Drug | 3-acetylisoquinoline | 1.39e-06 | 6 | 95 | 3 | CID000124656 | |
| Drug | Terazosin | 1.39e-06 | 6 | 95 | 3 | DB01162 | |
| Drug | Terazosin | 1.39e-06 | 6 | 95 | 3 | ctd:C041226 | |
| Drug | Guanadrel sulfate [22195-34-2]; Up 200; 7.6uM; HL60; HT_HG-U133A | 1.95e-06 | 200 | 95 | 8 | 2575_UP | |
| Drug | AR E | 5.48e-06 | 230 | 95 | 8 | CID004369394 | |
| Drug | ifenprodil | 1.19e-05 | 71 | 95 | 5 | CID000003689 | |
| Drug | St-1913 | 1.72e-05 | 2 | 95 | 2 | CID000123528 | |
| Drug | Neldazosin | 1.72e-05 | 2 | 95 | 2 | CID000065908 | |
| Drug | DL-028 | 1.72e-05 | 2 | 95 | 2 | CID005487531 | |
| Drug | quinazosin | 1.72e-05 | 2 | 95 | 2 | CID000027486 | |
| Drug | hydroxyphenacetyl aminoclonidine | 1.72e-05 | 2 | 95 | 2 | CID000173558 | |
| Drug | Midodrine | 1.72e-05 | 2 | 95 | 2 | DB00211 | |
| Drug | sulfonterol | 1.72e-05 | 2 | 95 | 2 | CID000170372 | |
| Drug | AC1L27FT | 1.72e-05 | 2 | 95 | 2 | CID000016192 | |
| Drug | paveril | 1.72e-05 | 2 | 95 | 2 | CID000006855 | |
| Drug | tolazine | 1.72e-05 | 2 | 95 | 2 | CID000101252 | |
| Drug | piclonidine | 1.72e-05 | 2 | 95 | 2 | CID000068914 | |
| Drug | Lidanserin | 1.72e-05 | 2 | 95 | 2 | CID000068919 | |
| Drug | glycylsarcosine | 1.72e-05 | 2 | 95 | 2 | ctd:C004194 | |
| Drug | FCE 22716 | 1.72e-05 | 2 | 95 | 2 | CID000125720 | |
| Drug | SKF 101253 | 1.72e-05 | 2 | 95 | 2 | CID000135152 | |
| Drug | ASL-7022 | 1.72e-05 | 2 | 95 | 2 | CID000173406 | |
| Drug | quinaprilat | 1.72e-05 | 2 | 95 | 2 | ctd:C054501 | |
| Drug | hoquizil | 1.72e-05 | 2 | 95 | 2 | CID000030690 | |
| Drug | Methoxamine | 1.72e-05 | 2 | 95 | 2 | DB00723 | |
| Drug | moexipril | 1.72e-05 | 2 | 95 | 2 | ctd:C058302 | |
| Drug | Prestwick_774 | 1.72e-05 | 2 | 95 | 2 | CID006420011 | |
| Drug | compound 44-549 | 1.72e-05 | 2 | 95 | 2 | CID000191431 | |
| Drug | 5-dembs | 1.72e-05 | 2 | 95 | 2 | CID000130379 | |
| Drug | levomepromazine sulfoxide | 1.72e-05 | 2 | 95 | 2 | CID000165566 | |
| Drug | R 56 | 1.72e-05 | 2 | 95 | 2 | CID009578362 | |
| Drug | dihydrolysergic acid amide | 1.72e-05 | 2 | 95 | 2 | CID000151000 | |
| Drug | St-404 | 1.72e-05 | 2 | 95 | 2 | CID000191786 | |
| Drug | AC1MBW4N | 1.72e-05 | 2 | 95 | 2 | CID002732234 | |
| Drug | Myordil | 1.72e-05 | 2 | 95 | 2 | CID000011282 | |
| Drug | 5-cfmbs | 1.72e-05 | 2 | 95 | 2 | CID000183818 | |
| Drug | IK29 | 1.72e-05 | 2 | 95 | 2 | CID000183825 | |
| Drug | pyrroxan | 1.72e-05 | 2 | 95 | 2 | CID000036302 | |
| Drug | dihydroergonine | 1.72e-05 | 2 | 95 | 2 | CID000193205 | |
| Drug | Indoramin | 1.72e-05 | 2 | 95 | 2 | ctd:D007217 | |
| Drug | penta-O-ethylquercetin | 1.72e-05 | 2 | 95 | 2 | CID000133942 | |
| Drug | clozapine | 1.95e-05 | 274 | 95 | 8 | CID000002818 | |
| Drug | Cloxacillin sodium salt [642-78-4]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 2.02e-05 | 199 | 95 | 7 | 2289_UP | |
| Drug | risperidone | 2.29e-05 | 136 | 95 | 6 | CID000005073 | |
| Drug | AC1L1KEH | 2.32e-05 | 40 | 95 | 4 | CID000005462 | |
| Drug | pseudococaine | ADRA1B ADRA1A SLC6A16 SLC6A5 STEAP4 GRIK4 BCL2 GRIK5 CABIN1 MMP16 MMP19 | 2.57e-05 | 570 | 95 | 11 | CID000002826 |
| Drug | TG-1 | 3.09e-05 | 15 | 95 | 3 | CID000060499 | |
| Drug | AC1Q5UBL | 3.41e-05 | 146 | 95 | 6 | CID000005466 | |
| Drug | Rec 15/2739 | 5.15e-05 | 3 | 95 | 2 | CID000148842 | |
| Drug | Farial | 5.15e-05 | 3 | 95 | 2 | CID000065979 | |
| Drug | mephentermine | 5.15e-05 | 3 | 95 | 2 | CID000003677 | |
| Drug | 1-(2-(3-methoxyphenyl)ethyl)phenoxy-3-(dimethylamino)-2-propanol | 5.15e-05 | 3 | 95 | 2 | ctd:C099060 | |
| Drug | Alfuzosin | 5.15e-05 | 3 | 95 | 2 | DB00346 | |
| Drug | Phenylephrine | 5.15e-05 | 3 | 95 | 2 | DB00388 | |
| Drug | spirapril | 5.15e-05 | 3 | 95 | 2 | ctd:C052555 | |
| Drug | Dapiprazole | 5.15e-05 | 3 | 95 | 2 | DB00298 | |
| Drug | Phendimetrazine | 5.15e-05 | 3 | 95 | 2 | DB01579 | |
| Drug | 2-(beta-(3-iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone | 5.15e-05 | 3 | 95 | 2 | ctd:C048008 | |
| Drug | SY28 | 5.15e-05 | 3 | 95 | 2 | CID000014606 | |
| Drug | MOPEG sulfate | 5.15e-05 | 3 | 95 | 2 | CID000004182 | |
| Drug | 2-FPE | 5.15e-05 | 3 | 95 | 2 | CID000127900 | |
| Drug | 4-FPE | 5.15e-05 | 3 | 95 | 2 | CID000127903 | |
| Drug | verticillatine | 5.15e-05 | 3 | 95 | 2 | CID000176717 | |
| Drug | Tamsulosin | 5.15e-05 | 3 | 95 | 2 | DB00706 | |
| Drug | abanoquil | 5.15e-05 | 3 | 95 | 2 | ctd:C058534 | |
| Drug | ifoxetine | 5.15e-05 | 3 | 95 | 2 | CID000071971 | |
| Drug | DB-6,7-ADTN | 5.15e-05 | 3 | 95 | 2 | CID000129816 | |
| Drug | chlorethylclonidine | 5.15e-05 | 3 | 95 | 2 | ctd:C051731 | |
| Drug | Wy 25309 | 5.15e-05 | 3 | 95 | 2 | CID000133818 | |
| Drug | 6-FPE | 5.15e-05 | 3 | 95 | 2 | CID000183822 | |
| Drug | XB513 | 5.15e-05 | 3 | 95 | 2 | CID000183813 | |
| Drug | metrenperone | 5.15e-05 | 3 | 95 | 2 | CID000072005 | |
| Drug | 5,7-dichlorokynurenic acid | 5.22e-05 | 49 | 95 | 4 | CID000001779 | |
| Drug | nifedipine | 6.00e-05 | 415 | 95 | 9 | CID000004485 | |
| Drug | Azone | 7.62e-05 | 20 | 95 | 3 | CID000042981 | |
| Drug | aminothiazole 6 | 1.03e-04 | 4 | 95 | 2 | CID005329388 | |
| Drug | Labetalol | 1.03e-04 | 4 | 95 | 2 | DB00598 | |
| Drug | tamsulosin | 1.03e-04 | 4 | 95 | 2 | ctd:C088482 | |
| Drug | 5-methoxygramine | 1.03e-04 | 4 | 95 | 2 | CID000027965 | |
| Drug | Tetraminol | 1.03e-04 | 4 | 95 | 2 | CID000125151 | |
| Drug | sertindole | 1.03e-04 | 4 | 95 | 2 | ctd:C066304 | |
| Drug | abanoquil | 1.03e-04 | 4 | 95 | 2 | CID000164088 | |
| Drug | BE 2254 | 1.03e-04 | 4 | 95 | 2 | ctd:C010652 | |
| Drug | 5-methylurapidil | 1.03e-04 | 4 | 95 | 2 | ctd:C057446 | |
| Drug | acromelic acid B | 1.03e-04 | 4 | 95 | 2 | CID000158974 | |
| Drug | Brn 1074551 | 1.03e-04 | 4 | 95 | 2 | CID000120220 | |
| Drug | NSC342008 | 1.03e-04 | 4 | 95 | 2 | CID000072602 | |
| Drug | 4-methyleneglutamic acid | 1.03e-04 | 4 | 95 | 2 | CID000096407 | |
| Drug | flupirtine | 1.03e-04 | 4 | 95 | 2 | ctd:C034161 | |
| Drug | diCl-HQC | 1.03e-04 | 4 | 95 | 2 | CID003018579 | |
| Drug | YM90K | 1.17e-04 | 23 | 95 | 3 | CID005486547 | |
| Drug | sodium | SLC25A3 GPR89B KCNH6 SLC15A1 SLC15A2 SLC6A16 SLC6A5 ABCB11 GRIK4 GRIK5 RIMS1 ANKH SLC7A10 | 1.48e-04 | 944 | 95 | 13 | CID000000923 |
| Drug | phendimetrazine | 1.51e-04 | 25 | 95 | 3 | CID000012460 | |
| Drug | Ramipril | 1.71e-04 | 26 | 95 | 3 | ctd:D017257 | |
| Drug | I heat | 1.71e-04 | 5 | 95 | 2 | CID000122216 | |
| Drug | Leniquinsin | 1.71e-04 | 5 | 95 | 2 | CID000025195 | |
| Drug | AC1L9NP0 | 1.71e-04 | 5 | 95 | 2 | CID000449842 | |
| Drug | propericiazine | 1.71e-04 | 5 | 95 | 2 | CID000004747 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.90e-06 | 195 | 93 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | non-high density lipoprotein cholesterol measurement | CEL MAP4K5 SCARB1 XRN1 ARFGEF2 ABCB11 GRIK5 TM6SF2 USP3 HDGFL2 SLC7A10 | 1.53e-05 | 713 | 93 | 11 | EFO_0005689 |
| Disease | aspartate aminotransferase measurement | SLC25A3 IL34 CLCN4 CEL MAP4K5 PIEZO1 SCARB1 DNAH2 ABCB11 BCL2 TM6SF2 GOLT1A | 2.72e-05 | 904 | 93 | 12 | EFO_0004736 |
| Disease | polycystic ovary syndrome (biomarker_via_orthology) | 3.87e-05 | 21 | 93 | 3 | DOID:11612 (biomarker_via_orthology) | |
| Disease | fasting blood glucose measurement, glucose tolerance test, fasting blood insulin measurement | 9.77e-05 | 5 | 93 | 2 | EFO_0004307, EFO_0004465, EFO_0004466 | |
| Disease | 1-myristoyl-2-docosahexaenoyl-GPC (14:0/22:6) measurement | 9.77e-05 | 5 | 93 | 2 | EFO_0800454 | |
| Disease | prolyl endopeptidase FAP measurement | 9.77e-05 | 5 | 93 | 2 | EFO_0021856 | |
| Disease | red blood cell density measurement | XRN2 ADRA1B MAP4K5 PIEZO1 RRM2B DNAH2 ARFGEF2 BCL2 INO80 USP3 SLC7A10 | 1.03e-04 | 880 | 93 | 11 | EFO_0007978 |
| Disease | lipoprotein measurement, phospholipid measurement | 1.54e-04 | 85 | 93 | 4 | EFO_0004639, EFO_0004732 | |
| Disease | mean corpuscular hemoglobin concentration | ACER2 INTU XRN2 MAP4K5 PIEZO1 SCARB1 ARFGEF2 ABCB11 BCL2 HDGFL2 SLC7A10 OR52A1 | 1.83e-04 | 1105 | 93 | 12 | EFO_0004528 |
| Disease | ciliopathy (implicated_via_orthology) | 2.75e-04 | 40 | 93 | 3 | DOID:0060340 (implicated_via_orthology) | |
| Disease | lymphocyte:monocyte ratio | 3.07e-04 | 288 | 93 | 6 | EFO_0600088 | |
| Disease | level of Sterol ester (27:1/16:1) in blood serum | 3.49e-04 | 9 | 93 | 2 | OBA_2045190 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 4.07e-04 | 197 | 93 | 5 | EFO_0005680 | |
| Disease | oleoyl-arachidonoyl-glycerol (18:1/20:4) [1] measurement | 4.35e-04 | 10 | 93 | 2 | EFO_0800507 | |
| Disease | lifestyle measurement, alcohol consumption measurement | 4.89e-04 | 115 | 93 | 4 | EFO_0007878, EFO_0010724 | |
| Disease | bilirubin measurement | 5.05e-04 | 442 | 93 | 7 | EFO_0004570 | |
| Disease | level of Ceramide (d40:1) in blood serum | 5.31e-04 | 11 | 93 | 2 | OBA_2045185 | |
| Disease | phosphatidylcholine 34:4 measurement | 6.35e-04 | 12 | 93 | 2 | EFO_0010378 | |
| Disease | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4) measurement | 6.35e-04 | 12 | 93 | 2 | EFO_0800453 | |
| Disease | non-alcoholic steatohepatitis | 6.35e-04 | 12 | 93 | 2 | EFO_1001249 | |
| Disease | myeloid white cell count | 7.43e-04 | 937 | 93 | 10 | EFO_0007988 | |
| Disease | facial pigmentation measurement | 7.84e-04 | 57 | 93 | 3 | EFO_0006942 | |
| Disease | Bipolar Disorder | 7.91e-04 | 477 | 93 | 7 | C0005586 | |
| Disease | polyunsaturated fatty acid measurement | 7.98e-04 | 131 | 93 | 4 | EFO_0010733 | |
| Disease | protein-glutamine gamma-glutamyltransferase e measurement | 9.11e-04 | 60 | 93 | 3 | EFO_0020690 | |
| Disease | lifestyle measurement, anxiety disorder measurement | 9.43e-04 | 137 | 93 | 4 | EFO_0007795, EFO_0010724 | |
| Disease | body surface area | 9.76e-04 | 643 | 93 | 8 | EFO_0022196 | |
| Disease | liver fat measurement, liver disease biomarker | 1.15e-03 | 16 | 93 | 2 | EFO_0006845, EFO_0010821 | |
| Disease | triacylglycerol 50:5 measurement | 1.15e-03 | 16 | 93 | 2 | EFO_0010412 | |
| Disease | Cannabis Dependence | 1.30e-03 | 17 | 93 | 2 | C0006870 | |
| Disease | protein C measurement | 1.30e-03 | 17 | 93 | 2 | EFO_0004633 | |
| Disease | Alzheimer's disease (is_marker_for) | 1.34e-03 | 257 | 93 | 5 | DOID:10652 (is_marker_for) | |
| Disease | triglyceride measurement, body mass index | 1.62e-03 | 19 | 93 | 2 | EFO_0004340, EFO_0004530 | |
| Disease | acetate measurement | 1.80e-03 | 20 | 93 | 2 | EFO_0010112 | |
| Disease | Depression, Bipolar | 2.02e-03 | 79 | 93 | 3 | C0005587 | |
| Disease | phosphatidylcholine measurement | 2.08e-03 | 284 | 93 | 5 | EFO_0010226 | |
| Disease | autoimmune disease | 2.22e-03 | 173 | 93 | 4 | EFO_0005140 | |
| Disease | diet measurement, HOMA-IR | 2.38e-03 | 23 | 93 | 2 | EFO_0004501, EFO_0008111 | |
| Disease | paracentral lobule volume measurement | 2.81e-03 | 25 | 93 | 2 | EFO_0010317 | |
| Disease | linoleic acid measurement | 2.88e-03 | 186 | 93 | 4 | EFO_0006807 | |
| Disease | lysophosphatidylethanolamine 18:2 measurement | 3.04e-03 | 26 | 93 | 2 | EFO_0010369 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AMWFPRRYLPKIFRN | 106 | Q5QJU3 | |
| FGEKLLGYFSWVMPV | 306 | Q9NS82 | |
| IENIYHSKPMRWPFF | 676 | Q99965 | |
| HSKPMRWPFFLFIPF | 681 | Q99965 | |
| FAWGPLNIPFMYLFS | 1086 | Q86SQ4 | |
| FVLCWLPFFLVMPIG | 281 | P35348 | |
| RPMFKLVWTPLLAAY | 891 | Q9Y6D5 | |
| FFIMPSYWCGKPRAV | 486 | Q99758 | |
| VRRILKFSAPEWPYM | 741 | O95342 | |
| GMFILCWLPFFIALP | 301 | P35368 | |
| PWYMAELFPFILLGV | 326 | P51793 | |
| LVFKQPWPGIMRTVY | 516 | Q9NR19 | |
| YLFSHPSRMPVYPKW | 436 | P19835 | |
| VIAPWRMPEFYNRFK | 141 | P00966 | |
| MYFLSGWPKRLLCPL | 1 | Q4ADV7 | |
| FTRWPKPRCKMYIPL | 31 | Q1W4C9 | |
| FTRFVPKFKVLPYWG | 586 | Q9ULG1 | |
| AKRKSFIGTPYWMAP | 166 | Q8IVH8 | |
| IRWMPPESILYRKFT | 691 | P04629 | |
| PEWALPLFLLFLFMY | 21 | Q8NGQ5 | |
| FYKGVAPLWMRQIPY | 216 | Q00325 | |
| SFPPDKMPLFQIYRW | 2161 | Q9Y3R5 | |
| KMPLFQIYRWAFIPE | 2166 | Q9Y3R5 | |
| FMYFLRGSLPWQGLK | 241 | Q9HCP0 | |
| MFMYFLRGSLPWQGL | 241 | P78368 | |
| YFKGWFLIDMVAAIP | 341 | Q9H252 | |
| KVWRYINFKMSPGFP | 356 | Q99542 | |
| PKMLGIFWFNVPEIY | 81 | Q9UKL2 | |
| GLTYQPEWKMPLFLV | 21 | Q8NGV7 | |
| MLSPTFVLWDVGYPL | 1 | A6NFA0 | |
| NLEFNWLLPYIMKFP | 351 | Q5XG92 | |
| VFAKMKGYPHWPARI | 16 | P51858 | |
| GKWFVKPELRPFYNM | 281 | Q6W3E5 | |
| RPGFSWPVMLFFSLY | 286 | Q9BRR3 | |
| PDWLGYMRFLVIPLG | 576 | Q86VP3 | |
| WLYFFSFLRLGMKAP | 681 | O94886 | |
| TVWAEPRLQIPMYFF | 46 | Q8NH79 | |
| RWPLLGMFLETYGFF | 81 | Q6ZVE7 | |
| VFAKMKGYPHWPARI | 11 | Q7Z4V5 | |
| MVIGWYKLFPPSSLV | 1651 | Q86UR5 | |
| VWLPLFMPVYLKLPS | 306 | A8MWK0 | |
| APPVMAYWVVGRLFL | 896 | Q9ULD6 | |
| LFKSFPGPMDWVPRY | 596 | O75173 | |
| MPRGFTWLRYLGIFL | 1 | Q6ZMJ4 | |
| PYILTLGAFFWMPFL | 136 | Q6E213 | |
| YLKAMGHKFLVRWPP | 491 | Q9Y6J0 | |
| AYPMPFCDRWGKLPL | 236 | Q9Y6W3 | |
| MYFFWKLGDPFPILS | 121 | B7ZAQ6 | |
| MYFFWKLGDPFPILS | 121 | P0CG08 | |
| RKMRYWLLPPFLAIV | 6 | Q05707 | |
| FRYLFGWMVPPKISL | 351 | Q15392 | |
| MVKFPALTHYWPLIR | 1 | Q9HCJ1 | |
| MLSPFWLHRNPKYFP | 366 | Q9NYL5 | |
| IIWLFERPHTMPKYL | 66 | A8MVW5 | |
| DPFSPGVWLFMLLAY | 541 | Q16099 | |
| PFSPAVWLFMLLAYL | 541 | Q16478 | |
| SWRYPPNAPFYKIMV | 2376 | Q9P225 | |
| TRVMFLYIPLPMFWA | 281 | P46059 | |
| RVLFLYIPLPMFWAL | 301 | Q16348 | |
| SYPMLKLVRLKLWFP | 191 | Q9BQ95 | |
| KRKSFIGTPYWMAPE | 171 | Q9Y4K4 | |
| KGFLPTLGPAWVNMY | 526 | Q9HC10 | |
| WMFPLERDFYPKARG | 261 | Q99487 | |
| RYGFLWPGLNVPLMK | 136 | P82675 | |
| FLLFLRLFPMTPNWF | 156 | Q96HV5 | |
| GVLEYWMRLRFPIKP | 746 | Q96KN7 | |
| LPPSVFWSFIFFLML | 491 | Q9GZN6 | |
| MNPLIYALFYPWFRK | 306 | Q96RI8 | |
| RLPLSPFWAIIFFLM | 556 | Q9Y345 | |
| FKPWSYIPDGIMPIF | 96 | Q68DH5 | |
| CPFLLMLLYWSIFPE | 351 | A1A5C7 | |
| PWKPGVFARVMIFLD | 791 | Q7RTY7 | |
| LSFNMWKEIPIPFYL | 51 | Q8WTV0 | |
| LKPSLKVWMTFPYGR | 331 | Q8N3P4 | |
| AFWTIPVYKPMHDFL | 221 | O15260 | |
| SYHPPIFRPMKRITW | 91 | Q9GZT8 | |
| MTFYLFGIRSFPKLW | 1 | O15091 | |
| FGIRSFPKLWKSPYL | 6 | O15091 | |
| FPPTRQMGLLFTWYD | 186 | Q8IUC4 | |
| TKMRGWFPFSYTRVL | 421 | Q9UQB8 | |
| LYGPSMRPLFDFSWL | 201 | P10415 | |
| GMEVFPVDLIYRPWK | 386 | A5YKK6 | |
| IFAKMKGYPHWPARV | 11 | O75475 | |
| RFVIFPIQYPDIWKM | 41 | Q7LG56 | |
| ITLWYKMILPPQFDR | 516 | Q12884 | |
| LVPSFIMPFKSKGYW | 271 | Q5M7Z0 | |
| YILGVMWSVLGFPLP | 241 | O15375 | |
| WLQKYGYLPPTDPRM | 46 | P51512 | |
| MGVPAFFRWLSRKYP | 1 | Q9H0D6 | |
| MGVPKFYRWISERYP | 1 | Q8IZH2 | |
| LFPMWRFPFYLSAVL | 196 | Q687X5 | |
| GFIPDLYAIPWFLTM | 616 | Q8TEA7 | |
| MWPFRLRCPIYFKTR | 1 | Q6ZVL8 | |
| SLFYVVWKIMPNFRG | 241 | Q9Y6I4 | |
| WAFALPYPRFRPMAS | 841 | Q92508 | |
| IPYLLVPCWAGMKVF | 176 | Q9BZW4 | |
| KYFDLGIWTAPISPM | 16 | Q9BR11 | |
| LPLGLPFYKWMLRQE | 1716 | Q14669 | |
| LLPKPMEFARVGGYW | 576 | Q9P2D8 | |
| PVTLPYQVYFMRKLW | 1881 | Q6PIF6 | |
| IPIGAYEPRWFMKYQ | 306 | Q6IQ20 |